Shanghai Fosun Pharmaceutical Financials

Market Capitalization CN¥61.86 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	23.13
Forward PE	19.72
Price to Sales TTM	CN¥1.53
Price to Book MRQ	CN¥1.40
Enterprise to Revenue	2.46
Enterprise to EBITDA	19.31

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	7.25%
Operating Margin	6.87%
Return on Assets TTM	1.42%
Return on Equity TTM	6.20%

Income Statement

Revenue TTM	CN¥40,330,264,576
Revenue per Share TTM	CN¥15.12
Quarterly Revenue Growth	-7.30%
Gross Profit TTM	CN¥19,061,747,712
EBITDA	CN¥6,136,622,084
Net Income to Common TTM	CN¥2,924,910,848
Diluted EPS TTM	CN¥1.10
Quarterly Earnings Growth YoY	25.40%

Balance Sheet

Total Cash MRQ	CN¥16,069,884,928
Total Cash per Share MRQ	CN¥6.09
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	59.57
Current Ratio MRQ	0.97
Book Value per Share MRQ	CN¥18.17

Cash Flow

Operating Cash Flow TTM	CN¥4,615,349,248
Levered Free Cash Flow TTM	CN¥-314,470,176

600196 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	2,671,326,465
Float Shares	1,659,445,215
Avg 10 Volume	13,518,577
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	42.81%
% Held by Institutions	11.46%

Stock Price Summary

Beta	1.18
Fifty Two Week Low	CN¥21.62
Fifty Two Week High	CN¥30.44
Fifty Two Week Change	13.88%
Day 50 MA	CN¥24.44
Day 200 MA	CN¥25.12

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.08
Forward Annual Dividend Yield	4.25%
Trailing Annual Dividend Rate	CN¥0.27
Trailing Annual Dividend Yield	1.06%
Payout Ratio	24.55%
Dividend Date
Ex Dividend Date	2024-08-06
Last Split Factor
Last Split Date	2010-07-26